Table 4.

The lipophilicity of all calcium channel blocker-associated chylous ascites.

Classification	Drug	Case Number	Lipophilicity	Incidence	Percentage *
Dihydropyridine	Manidipine	16	5.6	41.7% (15/36)	33.3 (16/48)
	Benidipine	2	4.6	100% (2/2)	4.2% (2/48)
	Nisoldipine	1	3.3	9.1% (1/11)	2.1% (1/48)
	Nifedipine	1	2.2	0.6% (1/159)	2.1% (1/48)
	Azelnidipine	1	6.0	N	2.1% (1/48)
	Amlodipine	1	3.0	N	2.1% (1/48)
	Lercanidipine	25	6.9	24.7% (19/77)	52.1 (25/48)
Benzothiazepine	Diltiazem	1	3.1	N	2.1% (1/48)

N: Unknown. * Number/ Total number.